| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c650bc189c0fd43656877b5aada02fea |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 |
| filingDate |
2017-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb0eaf7f1da79e27577ad6db2d2cae0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_253bb2eb3cbf0a115e661fb2d3249290
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_831fc834975f59c1851f2fe40ca3a47f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_761fb20221376009add10bb757841c71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25b411a42eeec0b3d4db4c91d82f46f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1baa3ced06e2437e4203c27a5a77561b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91e8fa0a4ded92fbb1da753e3cb559dd |
| publicationDate |
2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180009042-A |
| titleOfInvention |
Novel organosulfur derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating inflammatory diseases containing the same as an active ingredient |
| abstract |
The present invention relates to a novel organic sulfur compound, a process for producing the same, and a pharmaceutical composition for preventing or treating inflammatory diseases containing the same as an active ingredient. The novel organic sulfur compounds according to the present invention are useful as histone deacetylation (HDAC) In particular, it has been found that HDAC 1, 6 and 8 can be effectively inhibited at a concentration of nano-mol or micromole unit, and has excellent effects on inflammatory diseases such as inflammatory bowel disease, As a pharmaceutical composition for preventing or treating an inflammatory disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020095031-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113166047-A |
| priorityDate |
2016-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |